Cingulate Inc (CING)

Currency in USD
4.180
+0.120(+2.96%)
Closed·
4.178-0.002(-0.04%)
·
CING Scorecard
Full Analysis
Quickly burning through cash
CING is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.0004.180
52 wk Range
3.0206.010
Key Statistics
Prev. Close
4.06
Open
4.04
Day's Range
4-4.18
52 wk Range
3.02-6.01
Volume
131.65K
Average Volume (3m)
146.13K
1-Year Change
-13.28%
Book Value / Share
1.3
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CING Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
27.713
Upside
+563.00%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings downwards for the upcoming period

Cingulate Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Cingulate Inc Company Profile

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company’s lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials. It also develops CTx-2103 (buspirone) that is in a formulation stage for the treatment of anxiety and mental health disorders; and plans to initiate the clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD in children, adolescents, and adults. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

Compare CING to Peers and Sector

Metrics to compare
CING
Peers
Sector
Relationship
P/E Ratio
−1.3x−0.9x−0.7x
PEG Ratio
−0.02−0.010.00
Price/Book
4.3x2.2x2.6x
Price / LTM Sales
-1.7x3.4x
Upside (Analyst Target)
393.8%200.5%35.5%
Fair Value Upside
Unlock0.0%3.3%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 27.713
(+563.00% Upside)

Earnings

Latest Release
Aug 19, 2025
EPS / Forecast
-1.09 / -0.93
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CING Income Statement

People Also Watch

19.800
SOGP
+2.54%
1.9500
BIVI
-2.50%
1.550
ALLR
-4.32%
2.1100
SSKN
+1.93%
1.360
BCDA
+0.74%

FAQ

What Stock Exchange Does Cingulate Trade On?

Cingulate is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Cingulate?

The stock symbol for Cingulate is "CING."

What Is the Cingulate Market Cap?

As of today, Cingulate market cap is 23.43M.

What Is Cingulate's Earnings Per Share (TTM)?

The Cingulate EPS (TTM) is -5.47.

From a Technical Analysis Perspective, Is CING a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Cingulate Stock Split?

Cingulate has split 2 times.

How Many Employees Does Cingulate Have?

Cingulate has 0 employees.

What is the current trading status of Cingulate (CING)?

As of 04 Oct 2025, Cingulate (CING) is trading at a price of 4.180, with a previous close of 4.06. The stock has fluctuated within a day range of 4.000 to 4.180, while its 52-week range spans from 3.020 to 6.010.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.